Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Operating Room Turnover Kits are Saving Time, Money, and Preventing Infections

It seems healthcare professionals at care facilities are trying to do more with less time and resources: more patients, fewer nurses, less reimbursement from Medicare, and rising demands from health insurance companies. But at a time when some patients — an estimated 650,000 annually — are coming out of hospitals sicker than they were before…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

It seems healthcare professionals at care facilities are trying to do more with less time and resources: more patients, fewer nurses, less reimbursement from Medicare, and rising demands from health insurance companies.

But at a time when some patients — an estimated 650,000 annually — are coming out of hospitals sicker than they were before due to hospital-acquired infections, it’s clear that solutions are needed. To discuss this on today’s episode of the Healthcare Podcast, host Shelby Skrhak sat down with Adrienne Hamilton, Director of Marketing and Sales Operations for AliMed.

The Massachusetts-based company manufactures and sells healthcare products used in patient rooms, operating rooms, long-term health care facilities, and doctors’ offices. More than simply selling medical supplies, AliMed is partnering its company mission with the healthcare industry to save time, reduce costs, and substantially reduce the risk of infection for its patients.

“As a nation, we’re under a lot of pressure to reduce costs and certainly improve patient outcomes by reducing infection control,” Hamilton said. “Part of reducing costs is becoming more efficient.”

Hamilton shared how operating room turnover kits, a prepackaged bundle of disposable table sheets, pillowcases, arm board covers, hamper liners, and straps, are emerging as a trend in medical supplies and how she discovered the eminent need for them in one hospital setting, where nurses were asked to assemble similar kits for overtime.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512